CGPCS
KRTX

Capital Group Private Client Services’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital Group Private Client Services’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,009
Closed -$10.1M – 264
2023
Q4 		$10.1M Sell
32,009
-738
-2% -$143K 0.1% 138
2023
Q3 		$5.54M Sell
32,747
-54
-0.2% -$10.2K 0.07% 147
2023
Q2 		$7.11M Buy
32,801
+64
+0.2% +$13.7K 0.08% 138
2023
Q1 		$5.95M Buy
+32,737
New +$6.26M 0.07% 145

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Capital Group Private Client Services's KRTX Position: Q1 2024 in Review

Capital Group Private Client Services sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 32,009 shares — an estimated $10.1M sold.

Capital Group Private Client Services first reported a position in KRTX in Q1 2023 and held it in 4 quarters. The position peaked at $10.1M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Capital Group Private Client Services reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Capital Group Private Client Services sold 32,009 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $10.1M.
  • Capital Group Private Client Services first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • Capital Group Private Client Services's Karuna Therapeutics, Inc. Common Stock position peaked at $10.1M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Capital Group Private Client Services's 13F filing for Q1 2024, filed 14 May 2024.